RESEARCH
1. Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1.
Power R, Nolan J, Prado-Cabrero A, Coen R, Roche W, Power T, Howard A, Mulcahy R. J. Pers. Med. 2020, 10,43. Link to Study: Targeted
2. Nutritional Intervention to Prevent Alzheimer’s Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined.
Nolan JM, Mulcahy R, Power R, Moran R, Howard AN. Journal of Alzheimer’s Disease. June 2018. Link to Study: Nutritional Intervention to Prevent Alzheimer’s Disease:
3. The Relationship between Plasma Concentrations of Lutein and Zeaxanthin with Self-Reported and Actual Prevalence of AMD in an Irish population-Based Sample.
Moran R, Beatty S, Stack J, O’Halloran AM, Feeney J, Akuffo KO, Peto T, Kenny RA, Nolan JM. Current Eye Research. March 2018. Link to
4. Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Power R, Coen R, Beatty S, Mulcahy R, Moran R, Stack J, Howard AN, Nolan JM. Journal of Alzheimer’s Disease. January 2018. Link to Study: Supplemental
5. The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial
Akuffo KO, Beatty S, Peto T, Stack J, Stringham J, Kelly D, Leung I, Corcoran L, Nolan JM. Investigative Ophthalmology and Visual Science. October 2017.
6. Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations.
Phelan D, Prado-Cabrero A, Nolan JM. Nutrients. October 2017. Link to Study: Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations. Phelan D,
7. Relationship between macular pigment and visual function in subjects with early age-related macular degeneration.
Akuffo KO, Nolan JM, Peto T, Stack J, Leung I, Corcoran L, Beatty S. British Journal of Ophthalmology. February 2017. Link to Study: Relationship between macular
8. Enrichment of Macular Pigment Enhances Contrast Sensitivity in Subjects Free of Retinal Disease: Central Retinal Enrichment Supplementation Trials – Report 1.
Nolan JM, Power R, Stringham J, Dennison J, Stack J, Kelly D, Moran R, Akuffo KO, Corcoran L, Beatty S. Investigative Ophthalmology and Visual Science.
9. An Exploratory study evaluating the effects of macular carotenoid supplementation in various retinal disease
Crosby-Nwaobi R, Hykin P, Pete T, Sivaprasad, S. Clinical Ophthalmology. May 2016 Link to Study: An Exploratory study evaluating the effects of macular carotenoid supplementation
10. Lutein, zeaxanthin and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease.
Bernstein PS, Li B, Vachali PP, Gorusupudi A, Shyam R, Henriksen BS, Nolan JM. Progress in Retinal and Eye Research. November 2015. Link to Study: Lutein,
11. Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids.
Kelly D, Coen RF, Akuffo KO, Beatty S, Dennison J, Moran R, Stack J, Howard AN, Mulcahy R, Nolan JM. Journal of Alzheimer’s Disease. August
12. Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration.
Akuffo KO, Nolan JM, Howard AN, Moran R, Stack J, Klein R, Klein BE, Meuer SM, Sabour-Pickett S, Thurnham DI, Beatty S. Eye (London). May
13. The impact of supplemental macular carotenoids in Alzheimer’s disease: A randomized Clinical Trial.
Nolan JM, Loskutova E, Howard A, Mulcahy R, Moran R, Stack J, Bolger M, Coen RF, Dennison J, Akuffo KO, Owens N, Power R, Thurnham
14. Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.
Thurnham DI, Nolan JM, Howard AN, Beatty S. Graefes Archive for Clinical and Experimental Ophthalmology. October 2014. Link to Study: Macular response to supplementation with
15. Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration.
Sabour-Pickett S, Beatty S, Connolly E, Loughman J, Stack J, Howard A, Klein R, Klein BE, Meuer SM, Myers CE, Akuffo KO, Nolan JM. Retina.
16. Central Retinal Enrichment Supplementation Trials (CREST): Design and Methodology of the CREST Randomized Controlled Trials.
Akuffo KO, Beatty S, Stack J, Dennison J, O’Regan S, Meagher KA, Peto T, Nolan JM. Ophthalmic Epidemiology. April 2014. Link to Study: Central Retinal
17. Macular pigment, visual function, and macular disease among subjects with Alzheimer’s disease: An Exploratory Study.
Nolan JM, Loskutova E, Howard AN, Moran R, Mulcahy R, Stack J, Bolger M, Dennison J, Akuffo KO, Owens N, Thurnham DI, Beatty S. Journal
18. What is meso-zeaxanthin and where does it come from?
Nolan JM, Meagher K, Kashani S, Beatty S. Eye (London). August 2013. Link to Study: What is meso-zeaxanthin and where does it come from? Nolan
19. Macular pigment and its contribution to vision.
Loskutova E, Nolan JM, Howard A, Beatty S. Nutrients. May 2013. Link to Study: Macular pigment and its contribution to vision. Loskutova E, Nolan JM, Howard
20. Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration.
Meagher KA, Thurnham D, Beatty S, Howard AN, Connolly EE, Cummins W, Nolan JM. British Journal of Nutrition. December 2012. Link to Study: Serum response
21. The impact of macular pigment augmentation on visual performance using different carotenoid formulations.
Loughman J, Nolan JM, Howard AN, Conolly E, Meagher K, Beatty S. Investigative Ophthalmology and Visual Science. November 2012. Link to Study: The impact of
22. Profiles of Macular Pigment Optical Density and Their Changes Following Supplementation with Lutein and Zeaxanthin: Letter.
Nolan JM, Beatty S. Investigative Ophthalmology and Visual Science. September 2012. Link to Study: Profiles of Macular Pigment Optical Density and Their Changes Following Supplementation
23. Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment.
Nolan JM, Akkali M, Loughman J, Howard A, Beatty S. Experimental Eye Research. May 2012. Link to Study: Macular carotenoid supplementation in subjects with atypical
24. Supplementation with all three macular carotenoids: response, stability and safety.
Connolly EE, Beatty S, Loughman J, Howard AN, Louw MS, Nolan JM. Investigative Ophthalmology and Visual Science. November 2011. Link to Study: Supplementation with all
25. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
Connolly EE, Beatty S, Thurnham DI, Loughman J, Howard AN, Stack J, Nolan JM. Current Eye Research. April 2010. Link to Study: Augmentation of macular
26. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: The LUNA Study.
Trieschmann M, Beatty S, Nolan JM, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D. Experimental Eye Research. December 2006. Link to Study: Changes
